Zim Laboratories

14
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
71.41
0.41 (0.58%)
BSENSE

Dec 05

BSE+NSE Vol: 16.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
367.00
398.00
333.00
307.00
277.00
335.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
367.00
398.00
333.00
307.00
277.00
335.00
Expenditure (Ex Depriciation)
Stock Adjustments
-14.00
16.00
-9.00
-1.00
-6.00
0.00
Raw Materials Consumed
185.00
182.00
170.00
159.00
149.00
159.00
Power & Fuel Cost
13.00
11.00
9.00
7.00
7.00
7.00
Employee Cost
53.00
49.00
40.00
35.00
35.00
48.00
Operating Expenses
31.00
27.00
23.00
19.00
22.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
24.00
27.00
32.00
27.00
24.00
45.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
6.00
5.00
5.00
3.00
6.00
4.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
326.00
346.00
292.00
267.00
255.00
293.00
Operating Profit (PBDIT) excl Other Income
41.00
51.00
40.00
39.00
22.00
42.00
Other Income
5.00
6.00
4.00
2.00
4.00
2.00
Operating Profit (PBDIT)
46.00
58.00
45.00
42.00
27.00
44.00
Interest
6.00
5.00
8.00
10.00
12.00
10.00
Profit before Depriciation and Tax
39.00
52.00
37.00
31.00
14.00
33.00
Depreciation
15.00
17.00
16.00
15.00
14.00
11.00
Profit Before Taxation & Exceptional Items
23.00
35.00
21.00
15.00
0.00
22.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
23.00
35.00
21.00
10.00
0.00
22.00
Provision for Tax
6.00
10.00
6.00
2.00
-3.00
6.00
Profit After Tax
17.00
24.00
14.00
7.00
3.00
15.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
140.00
116.00
101.00
95.00
92.00
78.00
Profit Available for appropriations
157.00
141.00
116.00
102.00
95.00
93.00
Appropriations
157.00
141.00
116.00
102.00
95.00
93.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
5.00%
Earnings Per Share
3.54
5.01
2.99
4.50
2.03
9.52
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.78% vs -7.83% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 7.89% vs -21.66% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 64.43% vs 24.20% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -29.91% vs -33.00% in Mar 2024

Compare Profit and Loss Results of Zim Laboratories
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
367.00
133.00
234.00
175.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
367.00
133.00
234.00
175.94%
Expenditure (Ex Depriciation)
Stock Adjustments
-14.00
3.00
-17.00
-566.67%
Raw Materials Consumed
185.00
112.00
73.00
65.18%
Power & Fuel Cost
13.00
5.00
8.00
160.00%
Employee Cost
53.00
4.00
49.00
1,225.00%
Operating Expenses
31.00
3.00
28.00
933.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
1.00
23.00
2,300.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
5.00
1.00
20.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
326.00
138.00
188.00
136.23%
Operating Profit (PBDIT) excl Other Income
41.00
-4.00
45.00
1,125.00%
Other Income
5.00
5.00
0.00
0.00%
Operating Profit (PBDIT)
46.00
0.00
46.00
0%
Interest
6.00
0.00
6.00
0%
Profit before Depriciation and Tax
39.00
0.00
39.00
0%
Depreciation
15.00
2.00
13.00
650.00%
Profit Before Taxation & Exceptional Items
23.00
-1.00
24.00
2,400.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
23.00
-1.00
24.00
2,400.00%
Provision for Tax
6.00
0.00
6.00
0%
Profit After Tax
17.00
-2.00
19.00
950.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
140.00
52.00
88.00
169.23%
Profit Available for appropriations
157.00
49.00
108.00
220.41%
Appropriations
157.00
49.00
108.00
220.41%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.54
-0.51
4.05
794.12%
Profit And Loss - Net Sales
Net Sales 375.64 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.78% vs -7.83% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.89% vs -21.66% in Mar 2024

Profit And Loss - Interest
Interest 11.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 64.43% vs 24.20% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 11.74 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -29.91% vs -33.00% in Mar 2024